Personal information

No personal information available

Activities

Collapse all

Works (6)

S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers

Oncogene
2025-01-25 | Journal article
DOI: 10.1038/s41388-025-03276-5
Contributors: Samson Mugisha; Shahnawaz A. Baba; Shreyas Labhsetwar; Devam Dave; Aran Zakeri; Richard Klemke; Jay S. Desgrosellier
Source: check_circle
Crossref

S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers

2024-07-12 | Preprint
DOI: 10.21203/rs.3.rs-4559578/v1
Contributors: Jay Desgrosellier; Samson Mugisha; Shahnawaz Baba; Shreyas Labhsetwar; Devam Dave; Aran Zakeri; Richard Klemke
Source: check_circle
Crossref

A dataset of chromosomal instability gene signature scores in normal and cancer cells from the human breast

Data in Brief
2023-12 | Journal article
DOI: 10.1016/j.dib.2023.109647
Contributors: Shahnawaz A. Baba; Shreyas Labhsetwar; Richard Klemke; Jay S. Desgrosellier
Source: check_circle
Crossref

Breast cancer stem cells tolerate chromosomal instability during tumor progression via c-Jun/AXL stress signaling

Heliyon
2023-09 | Journal article
DOI: 10.1016/j.heliyon.2023.e20182
Contributors: Shahnawaz A. Baba; Qi Sun; Samson Mugisha; Shreyas Labhsetwar; Richard Klemke; Jay S. Desgrosellier
Source: check_circle
Crossref

Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1

npj Breast Cancer
2022-01-13 | Journal article
DOI: 10.1038/s41523-021-00375-w
Contributors: Qi Sun; Yufen Wang; Adam Officer; Brianna Pecknold; Garrett Lee; Olivier Harismendy; Jay S. Desgrosellier
Source: check_circle
Crossref

Combined Bcl-2/Src inhibition synergize to deplete stem-like breast cancer cells

Cancer Letters
2019-08 | Journal article
DOI: 10.1016/j.canlet.2019.05.004
Contributors: Qi Sun; Yufen Wang; Jay S. Desgrosellier
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Cell death and disease. (1)
Review activity for Oncogene. (1)
How many people are using ORCID?